The incidence of endstage renal disease due to glomerulosclerosis rises with aging in women, especially in minority populations. Women are relatively protected prior to menopause (F/M ratio =0.5), but after menopause this protection is lost (F/M ratio=1.0). Based on these data, we propose that estrogen deficiency after menopause is an important contributor to the development of progressive glomerulosclerosis, particularly in minority women. Glomerulosclerosis, defined as an excess deposition of extracellular matrix, is due to increased matrix synthesis and/or decreased degradation. Matrix metalloproteinases decrease deposition of matrix in vitro, and are linked to decreased glomerulosclerosis in vivo. We will use in vivo and in vitro mouse models of glomerulosclerosis, and human mesangial cell lines developed in our laboratory, as models of the kidney disease in majority (sclerosis-resistant) and minority (sclerosis-prone) women. We recently found that mesangial cells, the major source of sclerotic tissue in glomeruli, express estrogen receptors and that estrogen increases matrix metalloproteinase-2 (MMP-2) activity. We have additional preliminary data showing that the MMP-2 response to estrogen supplementation is blunted in sclerosis-prone mice. These data linking matrix turnover and estrogen response lead us to propose that estrogen retards glomerulosclerosis due, in part, to its stimulatory effect on matrix metalloproteinase-2 activity. A corollary proposal is that appropriate estrogen replacement would decrease the incidence of endstage renal disease in postmenopausal women. These proposals will be tested by identifying and characterizing estrogen receptor subtypes (ERalpha and ERbeta) and receptor activity in mesangial cells from women and sclerosis-prone and sclerosis-resistant mice, using a reporter construct under the transcriptional control of an estrogen responsive element. Mesangial cell MMP expression will be studied under conditions of estrogen deficiency, supplementation and antiestrogen treatment. The response to estrogen of cis-acting elements in the MMP-2 promoter will be studied in mesangial cells using MMP-2 promoter constructs. In addition, glomerular lesions and glomerular MMPs and collagen mRNA levels will be studied in ovariectomized mice in the presence of estrogen deficiency or supplementation and antiestrogen treatment. These data will provide data as to whether estrogen retards the progression of glomerulosclerosis in postmenopausal women. It may also provide tools to evaluate replacement therapy by estrogen analogues.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG017170-02
Application #
6169494
Study Section
General Medicine B Study Section (GMB)
Program Officer
Bellino, Francis
Project Start
1999-06-01
Project End
2003-05-31
Budget Start
2000-06-01
Budget End
2001-05-31
Support Year
2
Fiscal Year
2000
Total Cost
$349,172
Indirect Cost
Name
University of Miami School of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Miami
State
FL
Country
United States
Zip Code
33146
Rubio, Gustavo A; Catanuto, Paola; Glassberg, Marilyn K et al. (2018) Estrogen receptor subtype expression and regulation is altered in papillary thyroid cancer after menopause. Surgery 163:143-149
Catanuto, Paola; Xia, Xiaomei; Pereira-Simon, Simone et al. (2017) Estrogen receptor subtype ratio change protects against podocyte damage. Curr Trends Endocinol 9:19-29
Tashiro, Jun; Elliot, Sharon J; Gerth, David J et al. (2015) Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis. Transl Res 166:554-67
Catanuto, Paola; Fornoni, Alessia; Pereira-Simon, Simone et al. (2012) In vivo 17?-estradiol treatment contributes to podocyte actin stabilization in female db/db mice. Endocrinology 153:5888-95
Pereira-Simon, Simone; Xia, Xiaomei; Catanuto, Paola et al. (2012) Oxidant stress and mitochondrial signaling regulate reversible changes of ERýý expression and apoptosis in aging mouse glomeruli and mesangial cells. Endocrinology 153:5491-9
Doublier, Sophie; Lupia, Enrico; Catanuto, Paola et al. (2011) Estrogens and progression of diabetic kidney damage. Curr Diabetes Rev 7:28-34
Doublier, Sophie; Lupia, Enrico; Catanuto, Paola et al. (2011) Testosterone and 17?-estradiol have opposite effects on podocyte apoptosis that precedes glomerulosclerosis in female estrogen receptor knockout mice. Kidney Int 79:404-13
Linder, Jessica M; Pincus, David J; Panthaki, Zubin et al. (2009) Congenital anomalies of the hand: an overview. J Craniofac Surg 20:999-1004
Elliot, S J; Berho, M; Korach, K et al. (2007) Gender-specific effects of endogenous testosterone: female alpha-estrogen receptor-deficient C57Bl/6J mice develop glomerulosclerosis. Kidney Int 72:464-72
Karl, Michael; Berho, Mariana; Pignac-Kobinger, Judith et al. (2006) Differential effects of continuous and intermittent 17beta-estradiol replacement and tamoxifen therapy on the prevention of glomerulosclerosis: modulation of the mesangial cell phenotype in vivo. Am J Pathol 169:351-61

Showing the most recent 10 out of 23 publications